Hansen Natural
What analysts say
- Buy, sell, or hold?: Analysts strongly back Hansen Natural, with six of 10 rating it a buy and the remainder rating it a hold. Analysts like Hansen Natural better than competitor Dr Pepper Snapple Group overall. Wall Street has warmed to the stock over the past three months, with analysts increasing their endorsement from hold to moderate buy.
- Revenue forecasts: On average, analysts predict $436.3 million in revenue this quarter. That would represent a rise of 19.3% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.84 per share. Estimates range from $0.79 to $0.87.
What our community says
CAPS All-Stars are solidly backing the stock with 95.5% assigning it an outperform rating. The community at large agrees with the All-Stars with 92.8% awarding it a rating of outperform. Fools are bullish on Hansen Natural and haven't been shy with their opinions lately, logging 716 posts in the past 30 days. Even with a robust four out of five stars, Hansen Natural's CAPS rating falls a little short of the community's upbeat outlook.
Management
Hansen Natural's profit has risen year over year by an average of 22.6%. Revenue has now gone up for three straight quarters.
Quarter | Q1 | Q4 | Q3 | Q2 |
Gross Margin | 52.1% | 51.6% | 51.9% | 52.9% |
Operating Margin | 24.8% | 25.0% | 28.2% | 30.0% |
Net Margin | 15.4% | 15.4% | 17.4% | 17.5% |
For all our Hansen Natural-specific analysis, including earnings and beyond, add Hansen Natural to My Watchlist.
Motley Fool newsletter services have recommended buying shares of Hansen Natural. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.